爱迪特 reported revenue of ¥0.58B for the period ended 2026-06-30, +19.8% year on year. Net income was ¥0.11B, a 18.1% net margin on a 54.3% gross margin. The largest revenue line is 口腔修复材料 at 70% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.58B | +19.8% |
| Gross profit | ¥0.32B | — |
| Operating income | ¥0.12B | — |
| Net income | ¥0.11B | +16.9% |
| Gross margin | 54.3% | Net margin 18.1% |
| Revenue Q/Q | +26.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 口腔修复材料 | ¥0.41B | 69.9% |
| 口腔数字化设备 | ¥0.14B | 23.4% |
| 其他产品及服务 | ¥0.04B | 6.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.27B | 45.7% |
| R&D | ¥0.04B | 7.5% |
| SG&A | ¥0.14B | 24.6% |
| Tax & other | ¥0.01B | 1.7% |
| Item | Amount |
|---|---|
| Total assets | ¥2.52B |
| Total liabilities | ¥0.32B |
| Shareholders' equity | ¥2.20B |
| Equity / assets | 87.2% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 36% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
黄山谷捷 ・ 托伦斯 ・ 建发致新 ・ 蓝宇股份 ・ 佳力奇 ・ 中瑞股份 ・ 美新科技 ・ 诺瓦星云 ・ 优优绿能 ・ 肯特股份 ・ 六九一二 ・ 太力科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies